Referencias bibliográficas

  1. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018 Feb 26;20(2):12.
  2. Alkhulaifi F, Darkoh C. Meal Timing, Meal Frequency and Metabolic Syndrome. Nutrients. 2022 Apr 21;14(9):1719.
  3. Swarup S, Goyal A, Grigorova Y, Zeltser R. Metabolic Syndrome. 2022 Oct 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
  4. Alemany M. The Metabolic Syndrome, a Human Disease. Int J Mol Sci. 2024 Feb 13;25(4):2251.
  5. Wan KS, Mat Rifin H, Mohd Yusoff MF, Yoga Ratnam KK, Chan WK, Mohamad M, Mohd Noor N, Mustapha F, Ahmad NA. Prevalence of metabolic syndrome and metabolic dysfunction-associated fatty liver disease in Malaysia 2023: study protocol for a community-based nationwide cross-sectional survey. BMJ Open. 2023 Oct 27;13(10):e074432.
  6. Bonora, Enzo. “The Metabolic Syndrome and Cardiovascular Disease.” Annals of Medicine 38, no. 1 (2006): 64–80.
  7. Jha BK, Sherpa ML, Imran M, Mohammed Y, Jha LA, Paudel KR, Jha SK. Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology. Diabetology. 2023; 4(2):134-159.
  8. Das D, Shruthi NR, Banerjee A, Jothimani G, Duttaroy AK, Pathak S. Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies. Front Nutr. 2023 Aug 8;10:1221438.
  9. Giménez MC, Fernández Bosch A, Azorín Ras M, Martínez de la Torre C, Córcoles García S, Párraga Martínez I (2020). Metabolic syndrome and other cardiovascular risk modifiers in hypertensive adults aged 65 years or younger. Revista Clínica de Medicina de Familia, 13(3), 180-189.
  10. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017 Aug;11(8):215-225.
  11. Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022 Jan 12;23(2):786.
  12. Monserrat-Mesquida M, Quetglas-Llabrés M, Capó X, Bouzas C, Mateos D, Pons A, Tur JA, Sureda A. Metabolic Syndrome is Associated with Oxidative Stress and Proinflammatory State. Antioxidants (Basel). 2020 Mar 12;9(3):236.
  13. Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of Oxidative Stress in Metabolic Syndrome. Int J Mol Sci. 2023 Apr 26;24(9):7898.
  14. Lu Y, Wang M, Bao J, Chen D, Jiang H. Association between oxidative balance score and metabolic syndrome and its components in US adults: a cross-sectional study from NHANES 2011-2018. Front Nutr. 2024 Mar 13;11:1375060.
  15. Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt PI Jr. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016 Dec 15;473(24):4527-4550.
  16. McKeegan K, Mason SA, Trewin AJ, Keske MA, Wadley GD, Della Gatta PA, Nikolaidis MG, Parker L. Reactive oxygen species in exercise and insulin resistance: Working towards personalized antioxidant treatment. Redox Biol. 2021 Aug;44:102005.
  17. Hurrle S, Hsu WH. The etiology of oxidative stress in insulin resistance. Biomed J. 2017 Oct;40(5):257-262.
  18. Höhn A, Grune T. Lipofuscin: formation, effects and role of macroautophagy. Redox Biol. 2013 Jan 19;1(1):140-4.
  19. Song SB, Shim W, Hwang ES. Lipofuscin Granule Accumulation Requires Autophagy Activation. Mol Cells. 2023 Aug 31;46(8):486-495.
  20. Korac B, Kalezic A, Pekovic-Vaughan V, Korac A, Jankovic A. Redox changes in obesity, metabolic syndrome, and diabetes. Redox Biol. 2021 Jun;42:101887.
  21. Evangelou K, Gorgoulis VG. Sudan Black B, The Specific Histochemical Stain for Lipofuscin: A Novel Method to Detect Senescent Cells. Methods Mol Biol. 2017;1534:111-119.
  22. Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther. 2011 Dec;28(12):1105-13.
  23. Cho KH, Nam HS, Baek SH, Kang DJ, Na H, Komatsu T, Uehara Y. Beneficial Effect of Cuban Policosanol on Blood Pressure and Serum Lipoproteins Accompanied with Lowered Glycated Hemoglobin and Enhanced High-Density Lipoprotein Functionalities in a Randomized, Placebo-Controlled, and Double-Blinded Trial with Healthy Japanese. Int J Mol Sci. 2023 Mar 8;24(6):5185.
  24. Qiu L, Gao C, Wang H, Ren Y, Li J, Li M, Du X, Li W, Zhang J. Effects of dietary polyphenol curcumin supplementation on metabolic, inflammatory, and oxidative stress indices in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2023 Jul 14;14:1216708.
  25. Liasi E, Kantilafti M, Hadjimbei E, Chrysostomou S. Monacolin K supplementation in patients with hypercholesterolemia: A systematic review of clinical trials. Semergen. 2024 May-Jun;50(4):102156.
  26. Gasmi A, Asghar F, Zafar S, Oliinyk P, Khavrona O, Lysiuk R, Peana M, Piscopo S, Antonyak H, Pen JJ, Lozynska I, Noor S, Lenchyk L, Muhammad A, Vladimirova I, Dub N, Antoniv O, Tsal O, Upyr T, Bjørklund G. Berberine: Pharmacological Features in Health, Disease and Aging. Curr Med Chem. 2024;31(10):1214-1234.
  27. Marques C, Fernandes MH, Lima SAC. Elucidating Berberine’s Therapeutic and Photosensitizer Potential through Nanomedicine Tools. Pharmaceutics. 2023 Sep 5;15(9):2282.
  28. Sahibzada MUK, Sadiq A, Faidah HS, Khurram M, Amin MU, Haseeb A, Kakar M. Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity. Drug Des Devel Ther. 2018 Feb 14;12:303-312.
  29. Murakami T, Bodor E, Bodor N. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties. Expert Opin Drug Metab Toxicol. 2023 Mar;19(3):129-137.
  30. Murakami T, Bodor E, Bodor N. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations. Expert Opin Drug Metab Toxicol. 2023 Mar;19(3):139-148.